← Back to Patent Explorer
US4066743A Expired / Lapsed US ⏱️ 0.0 years remaining

X-ray contrast agents

Assignee: Mallinckrodt Inc
•
Filing: 1976-06-21
•
Granted: 1978-01-03
•
Expires: 1996-06-21
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 3-Acetamido-5-(4,4-bishydroxymethyl-2-oxazolinyl)-2,4,6-triiodobenzoic acid, 3-acetamido-5-(4-methyl-4-hydroxymethyl-2-oxazolinyl)-2,4,6-triiodoben zoic acid, analogous compounds and salts and esters thereof are useful as X-ray contrast agents. The corresponding acyl halides are useful as intermediates.

Inventors

  • 👤 Mills T. Kneller

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 21:47
CPC Classifications
C; C07; C07D; C07D263/00; C07D263/02; C07D263/08; C07D263/10; C07D263/14

Claims Analysis

Total Claims: 14
Claim 1
Independent Claim 50 words
A compound of the formula: ##STR5## wherein R 1 is hydroxymethyl and R 2 is selected from the group consisting of hydroxymethyl and a lower alkyl group containing between 1 and 4 carbon atoms, and esters thereof with lower alkanols, salts thereof with pharmaceutically acceptable cations, and acyl halides thereof.
Claim 2
Dependent Claim 50 words
A compound of the formula: ##STR5## wherein R 1 is hydroxymethyl and R 2 is selected from the group consisting of hydroxymethyl and a lower alkyl group containing between 1 and 4 carbon atoms, and esters thereof with lower alkanols, salts thereof with pharmaceutically acceptable cations, and acyl halides thereof.
Claim 3
Dependent Claim 11 words
A compound as defined in claim 1 which is 3-acetamido-5-(4,4-bishydroxymethyl-2-oxazolinyl)-2,4,6-triiodobenzoic acid.
Claim 4
Dependent Claim 19 words
A compound as defined in claim 1 which is a salt of 3-acetamido-5-(4,4-bishydroxymethyl-2-oxazolinyl)-2,4,6-triiodobenzoic acid with a pharmaceutically acceptable cation.
Claim 5
Dependent Claim 14 words
A compound as defined in claim 3 wherein the pharmaceutically acceptable cation is sodium.
Claim 6
Dependent Claim 14 words
A compound as defined in claim 3 wherein the pharmaceutically acceptable cation is N-methylglucamine.
Claim 7
Dependent Claim 11 words
A compound as defined in claim 1 which is 3-acetamido-5-(4-methyl-4-hydroxymethyl-2-oxazolinyl)-2,4,6-triiodobenzoic acid.
Claim 8
Dependent Claim 19 words
A compound as defined in claim 1 which is a salt of 3-acetamido-5-(4-methyl-4-hydroxymethyloxazolinyl)-2,4,6-triiodobenzoic acid with a pharmaceutically acceptable cation.
Claim 9
Dependent Claim 14 words
A compound as defined in claim 7 wherein the pharmaceutically acceptable cation is sodium.
Claim 10
Dependent Claim 14 words
A compound as defined in claim 7 wherein the pharmaceutically acceptable cation is N-methylglucamine.
Claim 11
Dependent Claim 32 words
An X-ray contrast medium comprising an aqueous solution of a salt of a compound selected from the group consisting of 3-acetamido-5-(4,4-bishydroxymethyl-2-oxazolinyl)-2,4,6-triiodobenzoic acid and 3-acetamido-5-(4-methyl-4-hydroxymethyl-2-oxazolinyl)-2,4,6-triiodobenzoic acid with at least one pharmaceutically acceptable cation.
Claim 12
Dependent Claim 32 words
An X-ray contrast medium comprising an aqueous solution of a salt of a compound selected from the group consisting of 3-acetamido-5-(4,4-bishydroxymethyl-2-oxazolinyl)-2,4,6-triiodobenzoic acid and 3-acetamido-5-(4-methyl-4-hydroxymethyl-2-oxazolinyl)-2,4,6-triiodobenzoic acid with at least one pharmaceutically acceptable cation.
Claim 13
Dependent Claim 15 words
An X-ray contrast medium as defined by claim 10 wherein said compound is 3-acetamido-5-(4,4-bishydroxymethyl-2-oxazolinyl)-2,4,6-triiodobenzoic acid.
Claim 14
Dependent Claim 15 words
An X-ray contrast medium as defined by claim 10 wherein said compound is 3-acetamido-5-(4-methyl-4-hydroxymethyl-2-oxazolinyl)-2,4,6-triiodobenzoic acid.

References Cited (Backward Citations)

US3310571A Cited
US3853965A Cited
US3917631A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1981-01-02 1981-07-04 1982-01-03 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1985-01-02 1985-07-04 1986-01-03 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1989-01-02 1989-07-04 1990-01-03 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag